Media

Click here for information on Embargos and Media Registrations.

CPD Points

Attendance at the Melanoma 2010 Conference will attract Continuing Professional Development points. Please click here for further information.

Hosted By

Melanoma Institute Australia

Major Sponsor

UOS

Platinum Sponsors

GSK-GlaxoSmithKline


Roche

Gold Sponsors

BMS Oncology

MSD

Provectus

Silver Sponsor

Abbott

Satchel Sponsor

Viralytics

Name Badge Sponsor

Oncovision

Poster Sponsor

Wiley-Blackwell / PCMR

Organising Committee

Nicholas Hayward (Convenor)
Diona Damian
Rod Dunbar
Nikolas Haass
Peter Hersey
Rick Kefford
Graham Mann
Richard Scolyer
Graham Stevens
Jonathan Stretch
John Thompson
Nicola Ware

Sponsored Symposia

Melanoma 2010 will feature several sponsored symposia sessions. Please see below for an outline of the programs. Please note these programs are current as at 5th October 2010 and are subject to change. For more information regarding the Sponsored Symposia please contact the Congress Managers.

Friday 5th November
Sponsor: BMS

1300 - 1400 BMS Lunch Symposium
Session Chairs: Peter Hersey Parkside 110 A & B
1300 - 1305 Introduction
Peter Hersey
1305 - 1320 Cancer Vaccines. Successes and failures
Jonathan Cebon
1320 - 1340 Overcoming Immunologic Tolerance to Melanoma: Targeting CTLA-4
F. Stephen Hodi
  Discussion

Saturday 6th November 2010
Sponsor: Roche

1300 - 1400 Advanced Melanoma – Finding a Tailored Solution for Patients
Session Chairs:  Richard Kefford Parkside 110A
1300 - 1305 Opening Remarks
Richard Kefford
1305 – 1315 The Evolution of Treatment for Advanced Melanoma: From Chemotherapy to Individualised Targeted Therapies
Axel Hauschild
1315 – 1325 Pivotal Signal Transduction Pathways in Melanoma
Grant McArthur
1325 – 1340 Advances in RAF Pathway Inhibitors for Advanced Melanoma
Jeffrey Sosman
1340 - 1400 Q&A and Closing Remarks
Richard Kefford

Saturday 6th November 2010
Sponsor: Abbott

1800 – 1900 Recent Advances in The Diagnosis of Melanoma
Session Chairs:  Richard Scolyer Parkside 110A
1800 – 1830 Targeting Immunotherapy in Patients with Melanoma
Peter Hersey
1830 – 1900 FISH for Melanoma diagnosis – the MSKCC experience
Klaus Busam